Mainz Biomed B.V.
MYNZ · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | – | $4,183 | $7,716 | $20,510 |
| - Cash | $1,911 | $6,236 | $978 | $7,071 |
| + Debt | $1,100 | $3,271 | $8,270 | $7,421 |
| Enterprise Value | – | $1,218 | $15,009 | $20,860 |
| Revenue | $287 | $373 | $521 | $215 |
| % Growth | -23.2% | -28.3% | 142.5% | – |
| Gross Profit | -$310 | $256 | $319 | $40 |
| % Margin | -108.2% | 68.6% | 61.3% | 18.7% |
| EBITDA | -$7,743 | -$10,087 | -$9,471 | -$12,611 |
| % Margin | -2,700.7% | -2,702.8% | -1,818.7% | -5,872% |
| Net Income | -$8,344 | -$10,627 | -$11,024 | -$5,183 |
| % Margin | -2,910.3% | -2,847.4% | -2,116.8% | -2,413.5% |
| EPS Diluted | -2.65 | -7.71 | -19.73 | -11.73 |
| % Growth | 65.6% | 60.9% | -68.2% | – |
| Operating Cash Flow | -$6,516 | -$8,945 | -$8,145 | -$4,655 |
| Capital Expenditures | -$1 | -$134 | -$121 | -$262 |
| Free Cash Flow | -$6,517 | -$9,080 | -$8,265 | -$4,917 |